Terveystalo shares tumbled approximately 12% in Helsinki trading after the private healthcare provider issued a profit warning for the full year.

The company announced it is lowering its adjusted operating profit (EBIT) guidance to a range of EUR 120 million to EUR 140 million, a significant downward revision that signals substantial headwinds in the second half of the year.

The market reaction was swift and severe, with investors digesting the implication that the company’s earlier financial projections were overly optimistic.

The guidance cut suggests that operational challenges or softer demand in the latter part of the year have eroded the profitability margin that analysts had previously modeled into their forecasts.

This repricing reflects a loss of confidence in the company’s ability to deliver on its initial targets.

Arvopaperi reported that the profit warning caught many market participants off guard, noting that the company’s previous guidance had relied heavily on strong second-half performance to balance the full-year results.

An analyst cited by the publication described the shortfall as more significant than initially anticipated, highlighting a disconnect between management’s earlier outlook and current operational realities.